This is the authors' abstract. We don't add key points for this paper.
The potential endocrine disruption activity of cyanotoxins, particularly their effects on estrogen and androgen receptors (ER, AR), remains poorly understood. In the present study, the potential agonistic/antagonistic estrogenic and androgenic activities of MC-LR and CYN have been determined for the first time with validated OECD Test Guidelines No. 455 and 458, respectively. The data show that only MC-LR demonstrated weak estrogenic agonistic effects (LogPC 10 value of −9.85 M), while both toxins displayed antagonistic effects on the ER, with LogIC 30 values of −4.4 and −6.4 for MC-LR and CYN, respectively. In addition, neither MC-LR nor CYN exhibited agonistic/antagonistic activities in AR. Docking studies revealed potential interactions between both toxins and AR, with CYN showing a higher predicted affinity for this receptor. In vivo studies, particularly those investigating androgen disruption, are warranted to confirm the endocrine disrupting potential of MC-LR and CYN. • Both toxins form complexes with ERα or AR after the in silico prediction. • MC-LR showed potential estrogenic activity acting as agonist/antagonist of the ER. • For CYN only antagonist effects of the ER were found. • No effects were found in the AR transactivation agonist and antagonist assays.
No takes yet. Share an insight, caveat, or question.
Casas-Rodríguez et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: